[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356396-105":59,"doc-detail-356396-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","genetic-evidence-linking-anti-polyomavirus-2-igg-seropositivity-to-ovarian-cancer-risk-observational-study","Genetic evidence linking anti-polyomavirus 2 IgG seropositivity to ovarian cancer risk - Observational Study","","Antibody-related immune phenotypes reflect long-term host–pathogen interactions and immunogenetic regulation, and have been increasingly implicated in cancer susceptibility. In ovarian cancer, immune-response associations with disease risk remain hard to interpret due to confounding and potential reverse causation. Using a 2-sample Mendelian randomization framework, the study tested genetically predicted antibody immune response phenotypes for causal links to ovarian cancer risk, primarily via inverse-variance weighted models. After multiple-testing correction, genetically predicted anti-polyomavirus 2 IgG seropositivity showed a modest increased risk (OR 1.062, 95% CI 1.027–1.099), with sensitivity analyses supporting limited pleiotropy and no reverse directionality. Results suggest a potential antibody-mediated immune role in ovarian cancer etiology among individuals of European ancestry.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetic-evidence-linking-anti-polyomavirus-2-igg-seropositivity-to-ovarian-cancer-risk-observational-study/356396/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetic-evidence-linking-anti-polyomavirus-2-igg-seropositivity-to-ovarian-cancer-risk-observational-study/356396.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of this observational study?","Question",{"text":112,"@type":113},"To evaluate whether genetically predicted antibody immune response phenotypes are causally linked to ovarian cancer risk, and to clarify associations that are difficult to interpret observationally.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study assess causality between antibody phenotypes and ovarian cancer?",{"text":117,"@type":113},"It used a 2-sample Mendelian randomization framework with genetic instruments from large GWAS and ovarian cancer summary statistics from FinnGen R12 and OpenGWAS, mainly estimating effects using inverse-variance weighted models.",{"name":119,"@type":110,"acceptedAnswer":120},"Which antibody phenotype showed an association with ovarian cancer risk?",{"text":121,"@type":113},"Genetically predicted anti-polyomavirus 2 IgG seropositivity was associated with a modest increase in ovarian cancer risk after meta-analysis and multiple-comparison correction (OR 1.062, 95% CI 1.027–1.099).",{"name":123,"@type":110,"acceptedAnswer":124},"Did sensitivity and reverse-direction analyses support confounding or reverse causation?",{"text":125,"@type":113},"Sensitivity analyses did not indicate substantial pleiotropic bias, and reverse-direction analyses provided no support for ovarian cancer influencing anti-polyomavirus 2 IgG levels.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},356396,1790141541,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","®  \n Observational Study   \nGenetic evidence linking anti-polyomavirus 2 IgGseropositivity to ovarian cancer risk  \nWeichu Zhang, MMa , Zhuorong Gu, MMb , Guanghui Song, MMc , Shaohan Zou, MMc , Shihao Hong, MMc ,*  \n\n| Abstract\u003Cbr>Antibody-related immune phenotypes reflect long-term host–pathogen interactions and immunogenetic regulation, and have been increasingly implicated in cancer susceptibility. In ovarian cancer, observational associations between immune responsesand disease risk remain difficult to interpret due to confounding and potential reverse causation. Genetic analyses may help clarify whether specific antibody immune response profiles are linked to ovarian cancer risk. We investigated the associations between 46 genetically predicted antibody immune response phenotypes and ovarian cancer using a 2-sample Mendelian randomization framework. Genetic instruments for antibody traits were obtained from large genome-wide association studies, while ovarian cancer summary statistics were derived independently from the FinnGen R12 and OpenGWAS resources. Causal estimates were derived primarily using inverse-variance weighted models and subsequently synthesized across datasets to improve precision. Multiple testing adjustment was applied, and additional analyses were conducted to assess robustness and causal directionality. Across the evaluated antibody phenotypes, most showed no evidence of a causal association with ovarian cancer risk. After meta-analysis and correction for multiple comparisons, genetically predicted anti-polyomavirus 2 immunoglobulin G (IgG) seropositivity was associated with a modest increase in ovarian cancer risk (odds ratio = 1.062, 95% confidence interval: 1.027–1.099) . Sensitivity analyses did not indicate substantial pleiotropic bias, and reverse-direction analyses provided no support for ovarian cancer influencing anti-polyomavirus 2 IgG levels. These findings suggest that genetic liability to anti-polyomavirus 2 IgG seropositivity, as a marker of immune response rather than active infection, is modestly associated with ovarian cancer risk in individuals of European ancestry. Although the effect size is small, the results highlight a potential role for antibody-mediated immune processes in ovarian cancer etiology and warrant further investigation in diverse populations and experimental settings. |\n| --- |\n| Abbreviations: CI = confidence interval , GWAS = genome-wide association study/studies, HLA = human leukocyte antigen, IgG = immunoglobulin G, IVW = inverse-variance weighted, JCPyV = JC polyomavirus, LD = linkage disequilibrium, MR = Mendelian randomization, MR-Egger = Mendelian randomization Egger regression, MR-PRESSO = Mendelian Randomization Pleiotropy RESidual Sum and Outlier, OR = odds ratio. |\n| Keywords: antibody-mediated immunity, immune response phenotypes, Mendelian randomization, ovarian cancer, polyomavirus 2 IgG |\n\n1. Introduction  \nOvarian cancer remains a leading cause of gynecologic cancer– related mortality worldwide, with marked geographic variation in incidence and outcomes. Despite ongoing advances in  \nWZ and ZG contributed to this article equally.  \nThe authors have no funding and conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this published article [and its supplementary information files].  \nAll participants included in the FinnGen study provided informed consent in accordance with the Finnish Biobank Act or through study-specific consent procedures approved prior to the enactment of the Act. The FinnGen study protocol was approved by the Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa (HUS/990/2017) and relevant national authorities in Finland. The present study used publicly available, summary-level genomewide association data from FinnGen and other consortia. No individual-level data were accessed, and no additional ethical approval was required for this secondary analysis. Th","cbCaip7TbnmLQpdE","https://ap.wps.com/l/cbCaip7TbnmLQpdE","pdf",1810202,"English","# Abstract\n# Abbreviations\n# Keywords\n# Introduction","[{\"question\":\"What was the main aim of this observational study?\",\"answer\":\"To evaluate whether genetically predicted antibody immune response phenotypes are causally linked to ovarian cancer risk, and to clarify associations that are difficult to interpret observationally.\"},{\"question\":\"How did the study assess causality between antibody phenotypes and ovarian cancer?\",\"answer\":\"It used a 2-sample Mendelian randomization framework with genetic instruments from large GWAS and ovarian cancer summary statistics from FinnGen R12 and OpenGWAS, mainly estimating effects using inverse-variance weighted models.\"},{\"question\":\"Which antibody phenotype showed an association with ovarian cancer risk?\",\"answer\":\"Genetically predicted anti-polyomavirus 2 IgG seropositivity was associated with a modest increase in ovarian cancer risk after meta-analysis and multiple-comparison correction (OR 1.062, 95% CI 1.027–1.099).\"},{\"question\":\"Did sensitivity and reverse-direction analyses support confounding or reverse causation?\",\"answer\":\"Sensitivity analyses did not indicate substantial pleiotropic bias, and reverse-direction analyses provided no support for ovarian cancer influencing anti-polyomavirus 2 IgG levels.\"}]","Genetic evidence linking anti-polyomavirus 2 IgG seropositivity to ovarian cancer risk - Observational Study | PDF",1790125175,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/820b3a98e15572718795652b59409905.webp",983,1310,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/146f2467faa9a0eaf16b7075d1327680.webp",982,1309,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/210f2ad1e8841365da0575924ef1a314.webp",981,1308,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a9768167a7cb70e92e595af181c6308.webp",980,1306]